Crossmark

Girdin silencing enhances mebendazole-mediated anticancer activity: a combinatorial therapeutic strategy for ovarian cancer

Crossref DOI link: https://doi.org/10.1007/s12032-025-03210-5

Published Online: 2025-12-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gupta, Rahul https://orcid.org/0000-0003-1531-9594
Begum, Yasmin https://orcid.org/0000-0003-2482-8534
Ghosh, Dipanjan https://orcid.org/0000-0003-3266-9262
Swarnakar, Snehasikta https://orcid.org/0000-0002-7139-9683
License Information

Text and Data Mining valid from 2025-12-29

Version of Record valid from 2025-12-29
More Information

Article History

Received: 23 August 2025

Accepted: 14 December 2025

First Online: 29 December 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.